Large BRCA1 and BRCA2 genomic rearrangements in Polish high-risk breast and ovarian cancer families

Molecular Biology Reports

Volumn 40, Issue 12, 2013, Pages 6619-6623

  Rudnicka, Helena ^a   Debniak, Tadeusz ^a   Cybulski, Cezary ^a   Huzarski, Tomasz ^a   Gronwald, Jacek ^a   Lubinski, Jan ^a   Gorski, Bohdan ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

BRCA1; BRCA2; Breast cancer; Cancer diagnostics; Germline mutations; Large gnomic rearrangements

Indexed keywords

ARTICLE; BREAST CANCER; ETHNIC GROUP; EXON; FAMILY HISTORY; FEMALE; GENE DELETION; GENE MUTATION; GENE REARRANGEMENT; HIGH RISK POPULATION; HUMAN; LARGE GENOMIC REARRANGEMENT; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; OVARY CANCER; POLAND; POLISH; POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

ADULT; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; FAMILY; FEMALE; GENE REARRANGEMENT; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; POLAND; RISK FACTORS;

EID: 84890418327     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-013-2775-0     Document Type: Article

References (39)

1. Górski B, Byrski T, Huzarski T, Jakubowska A et al (2000) Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. Am J Hum Genet 66:1963-1968
2. Grzybowska E, Zientek H, Jasinska A et al (2000) High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer. Hum Mutat 16:482-490
3. van Der Looij M, Wysocka B, Brozek I et al (2000) Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland. Hum Mutat 15:480-481
4. Schouten JP, McElgunn CJ, Waaijer R et al (2002) Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 30:e57
5. Puget N, Torchard D, Serova-Sinilnikova OM et al (1997) A 1-kb Alu-mediated germline deletion removing BRCA1 exon 17. Cancer Res 57:3-828
6. HGMB-The Human Gene Mutation Database at the Institute of Medical Genetics in Cardiff: http://www.hgmd.cf.ac.uk
7. Montagna M, Dalla Palma M, Menin C et al (2003) Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families. Hum Mol Genet 12:1055-1061. doi: 10.1093/hmg/ddg120
8. Hogervorst FB, Nederlof PM, Gille JJ et al (2003) Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res 63:1449-1453
9. Sluiter MD, van Rensburg EJ (2011) Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation. Breast Cancer Res Treat 125:325-349. doi: 10.1007/s10549-010-0817-z
10. Ratajska M, Brozek I, Senkus-Konefka E et al (2008) BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland. Oncol Rep 19:263-268
11. Jakubowska A, Górski B, Byrski T et al (2001) Detection of germline mutations in the BRCA1 gene by RNA-based sequencing. Hum Mutat 18:149-156
12. denDunnen JT, Antonarakis SE (2001) Nomenclature for the description of human sequence variations. Hum Genet 109:121-124
13. ReapetMasker: http://www.repeatmasker.org
14. Agata S, Viel A, Della Puppa L, Cortesi L et al (2006) Prevalence of BRCA1 genomic rearrangements in a large cohort of Italian breast and breast/ovarian cancer families without detectable BRCA1 and BRCA2 point mutations. Genes Chromosom Cancer 45:791-797
15. Hartmann C, John AL, Klaes R et al (2004) Large BRCA1 gene deletions are found in 3 % of German high-risk breast cancer families. Hum Mutat 24:534
16. Gad S, Caux-Moncoutier V, Pagès-Berhouet S et al (2002) Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families. Oncogene 21:6841-6847
17. Vasickova P, Machackova E, Lukesova M et al (2007) High occurrence of BRCA1 intragenic rearrangements in hereditary breast and ovarian cancer syndrome in the Czech Republic. BMC Med Genet 8:32. doi: 10.1186/1471-2350-8-32
18. Thomassen M, Gerdes AM, Cruger D et al (2006) Low frequency of large genomic rearrangements of BRCA1 and BRCA2 in western Denmark. Cancer Genet Cytogenet 168:168-171
19. Krajc M, Teugels E, Zgajnar J et al (2008) Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families. BMC Med Genet 9:83. doi: 10.1186/1471-2350-9-83
20. Walsh T, Casadei S, Coats KH et al (2006) Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA 295:1379-1388
21. Palma MD, Domchek SM, Stopfer J et al (2008) The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families. Cancer Res 68:7006-7014. doi: 10.1158/0008-5472
22. Distelman-Menachem T, Shapira T, Laitman Y et al (2009) Analysis of BRCA1/BRCA2 genes' contribution to breast cancer susceptibility in high risk Jewish Ashkenazi women. Fam Cancer 8:127-133. doi: 10.1007/s10689-008-9216-6
23. Stadler ZK, Saloustros E, Hansen NA et al (2011) Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families. Breast Cancer Res Treat 123:581-585. doi: 10.1007/s10549-010-0818-y
24. Ticha I, Kleibl Z, Stribrna J et al (2010) Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene. Breast Cancer Res Treat 124:337-347. doi: 10.1007/s10549-010-0745-y
25. Janavičius R (2010) Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control. EPMA J 1:397-412. doi: 10.1007/s13167-010-0037-y
26. Petrij-Bosch A, Peelen T, van Vliet M et al (1997) BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet 17:341-345
27. Hendrickson BC, Judkins T, Ward B et al (2005) Prevalence of five previously reported and recurrent BRCA1 genetic rearrangement mutations in 20,000 patients from hereditary breast/ovarian cancer families. Genes Chromosom Cancer 43:309-313
28. Mazoyer S (2005) Genomic rearrangements in the BRCA1 and BRCA2 genes. Hum Mutat 25:415-422
29. Peelen T, van Vliet M, Bosch A et al (2000) Screening for BRCA2 mutations in 81 Dutch breast-ovarian cancer families. Br J Cancer 82:151-156
30. Lahti-Domenici J, Rapakko K, Pääkkönen K et al (2001) Exclusion of large deletions and other rearrangements in BRCA1 and BRCA2 in Finnish breast and ovarian cancer families. Cancer Genet Cytogenet 129:120-123
31. Agata S, Dalla Palma M, Callegaro M et al (2005) Large genomic deletions inactivate the BRCA2 gene in breast cancer families. J Med Genet 42:e64. doi: 10.1136/jmg.2005.032789
32. Tournier I, Paillerets BB, Sobol H et al (2004) Significant contribution of germline BRCA2 rearrangements in male breast cancer families. Cancer Res 64(22):8143-8147
33. Casilli F, Tournier I, Sinilnikova OM et al (2006) The contribution of germline rearrangements to the spectrum of BRCA2 mutations. J Med Genet 43:e49
34. Gutiérrez-Enríquez S, de la Hoya M, Martínez-Bouzas C et al (2007) Screening for large rearrangements of the BRCA2 gene in Spanish families with breast/ovarian cancer. Breast Cancer Res Treat 103:103-107. doi: 10.1007/s10549-006-9376-8
35. Del Valle J, Feliubadalo L, Nadal M et al (2009) Identification and comprehensive characterization of large genomic rearrangements in the BRCA1 and BRCA2 genes. Breast Cancer Res Treat 122:733-743. doi: 10.1007/s10549-009-0613-9
36. Nordling M, Karlsson P, Wahlström et al (1998) A large deletion disrupts the exon 3 transcription activation domain of the BRCA2 gene in a breast/ovarian cancer family. Cancer Res 58:1372-1375
37. Machado PM, Brandão RD, Cavaco BM et al (2007) Screening for a BRCA2 rearrangement in high-risk breast/ovarian cancer families: evidence for a founder effect and analysis of the associated phenotypes. J ClinOncol 25:2027-2034. doi: 10.1200/JCO.2006.06.9443
38. Peixoto A, Santos C, Rocha P et al (2009) The c.156-157insAlu BRCA2 rearrangement accounts for more than one-fourth of deleterious BRCA mutations in northern/central Portugal. Breast Cancer Res Treat 114:31-38. doi: 10.1007/s10549-008-9978-4
39. Woodward AM, Davis TA, Silva AG et al (2005) Large genomic rearrangements of both BRCA2 and BRCA1 are a feature of the inherited breast/ovarian cancer phenotype in selected families. J Med Genet 42(5):e31